Home › Studies › PRJEB55366
PRJEB55366 ERP140254

Gut microbiome and mCRC therapy response in Taiwan

A collection of whole genome sequencing (WGS) datasets from patients with colorectal cancer. Patients were treated with chemotherapy and target therapies (anti-VEGF or anti-EGFR) and showed different responses. Samples come from stool.

54 stool samples from Taiwanese patients with metastatic colorectal cancer, collected before chemotherapy plus targeted therapy (anti-EGFR or anti-VEGF); a case-control design compared patients with progressive disease versus partial response. machine-written summary

54 samples · 54 runs · TW · Adult · 2022 · 10.32 Gbp / sample

Sources
✓Sequence archive 324○Abstract / description○Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive324 sample values (collection date, country, health condition, health condition detail, latitude, longitude)
○ Abstract / descriptionread; no usable statement
○ Full textread; no usable statement or table · PMC9539537
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 sampling locations · 1 country
Age
adult54
Condition
colorectal_cancer54
Country
TW54
Body site
primary54
Collected 2018–2020
2018: 7 samples2019: 30 samples2020: 17 samples20182020
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 2 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)this project, 0.3–1 Gbp: 2 samplesall projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 2 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 19 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 29 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 10.32 Gbp per sample0130Gbp
Community composition
Bacteroides 15.9%Phocaeicola 7.9%Akkermansia 5.6%Bifidobacterium 5.2%Alistipes 4.5%Escherichia 3.8%Streptococcus 2.7%Klebsiella 2.7%Blautia_A 2.0%Collinsella 1.8%Mediterraneibacter 1.6%Faecalibacterium 1.5%not assigned to a genus 6.2%other genera 38.5%

Genera, mean relative abundance over 51 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category54 100%
country54 100%54
health_condition54 100%54
subject_id0 0%
collection_date54 100%54
health_condition_detail54 100%54
latitude54 100%54
longitude54 100%54
Papers (1)
  • Gut microbiota composition in chemotherapy and targeted therapy of patients with metastatic colorectal cancer. 2022 PMID 36212420 PMC9539537 own_data
Details
Archive description

This study investigates the role of the gut microbiome in the treatment of metastatic colorectal cancer (mCRC) patients. Stools from patients before chemotherapy and targeted therapy were collected and performed whole genome sequencing. Patients with progressive disease or partial response to the therapy were included in this study.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “from patients with colorectal cancer. Patients were”
  • body site study.description · “role of the gut microbiome in the”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA110645760collection_date2019-07-06R10.90biosample.attribute:collection_date2019-07-06
SAMEA110645760countryTWR10.90sample.attr.geographic_location_country_and_or_seaTaiwan
SAMEA110645760health_conditioncolorectal_cancerR10.90biosample_attrcolorectal carcinoma
SAMEA110645760health_condition_detailcolorectal carcinomaR10.90sample.attr.host_disease_statuscolorectal carcinoma
SAMEA110645760latitude23.6978R10.90biosample.attribute:geographic_location_latitude+geographic_location_longitude23.6978 120.9605
SAMEA110645760longitude120.9605R10.90biosample.attribute:geographic_location_latitude+geographic_location_longitude23.6978 120.9605
Sequencing

54 runs over 54 samples · mean 10.53 Gbp per run (median 10.32 Gbp, total 568.86 Gbp; 54 runs with a base count) · layout PAIRED 54 · platform ILLUMINA 54 · models HiSeq X Ten (54) · 94% of runs with a Sandpiper profile · first public 2022-09-08

Authors (10)

Chen YC first · Chuang CH · Miao ZF · Yip KL · Liu CJ · Li LH · Wu DC · Cheng TL · Lin CY · Wang JY last

Downloads

PRJEB55366.csv.gz (2.4 KB) · parquet (71.6 KB) — all 54 samples, every field with route and confidence · PRJEB55366_determinations.csv.gz (2.4 KB) — 324 evidence rows

Samples (54 · every field this project has values for · hover a cell for its source)
Loading the sample table…